Sphingomonas koreensis

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Sphingomonas koreensis is a Gram-negative, non-spore-forming, aerobic, motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 66%. Sphingomonas koreensis is likely to be transient and not a long-term gut coloniser. (Lee2001a)



  • This organism has been recovered from human faeces and mineral water from Korea. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • GENERAL CHARACTERISTICS (Lee2001a);
    Character Response
  • ⥅
  • Substrates assimilated or utilised:
  • N-acetylglucosamine; arbutin; cellubiose; fructose; glucose; maltose; rhamnose; sucrose; xylose; alanine; histidine; proline; glutarate; 3-hydroxybutyrate; malate; suberate;
  • Active enzymes:
  • catalase; β-galactosidase; lipase; oxidase;
    • SPECIAL FEATURES (Lee2001a);
    Character Response
  • ✗
  • Metabolites not produced:
  • indole;
  • ✗
  • Nitrate:
  • not reduced
  • Pigments:
  • yellow

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Alphaproteobacteria Order:  Sphingomonadales Family:  Sphingomonadaceae Genus:  Sphingomonas Gram stain:  neg O2 Relation.:  aerobic Spore:  No spore Motility:  Swimming Morphology:  Rod Pigment:  yellow
    Health:  Unknown
    Source:  human faeces and mineral water from Korea
    DNA G+C(%):  66
    		Aesculin:  vr Urea:  neg Gelatin:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  neg Glucose:  neg Mannose:  neg Rhamnose:  w Xylose:  neg Cellubiose:  neg Lactose:  neg Maltose:  neg Melibiose:  neg Sucrose:  neg Trehalose:  neg Adonitol:  neg D-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  neg Inositol:  neg Mannitol:  neg Sorbitol:  neg Me-α-D-Glc:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Fructose:  + Galactose:  neg Glucose:  + Mannose:  neg Rhamnose:  + Ribose:  neg Xylose:  + Cellubiose:  + Maltose:  + Melibiose:  vr Raffinose:  neg Sucrose:  + N_Acetyl_glucosamine:  + Adonitol:  neg Arbutin:  + Gluconate:  neg Glycogen:  neg Inositol:  neg Mannitol:  neg Salicin:  vr Sorbitol:  neg Ala:  + β-Ala:  neg 4-Aminobutyrate:  neg Asp:  neg His:  + Leu:  neg Orn:  neg Phe:  neg Pro:  + Ser:  neg Trp:  neg Acetate:  neg Aconitate:  neg Adipate:  neg Azelate:  neg Caprate:  neg Citrate:  neg Fumarate:  neg Glutarate:  + 3-Hydroxybutyrate:  + 3-Hydroxybenzoate:  neg 4-Hydroxybenzoate:  neg Itaconate:  neg 2-Ketogluconate:  neg 5-Ketogluconate:  neg DL-Lactate:  neg Malate:  + Mesaconate:  w Phenylacetate:  neg Propionate:  neg Pyruvate:  w Suberate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  + Urease:  neg β-Galactosidase:  + β-Glucosidase:  neg ArgDH:  neg Lipase:  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Indole:  neg Pigment:  yellow

    References

    SPECIFIC REFERENCES FOR SPHINGOMONAS KOREENSIS
  • Lee2001a - Sphingomonas aquatilis sp. nov., Sphingomonas koreensis sp. nov., and Sphingomonas taejonensis sp. nov., yellow-pigmented bacteria isolated from natural mineral water.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR SPHINGOMONAS KOREENSIS
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • ...............................
    • Added: December 15, 2021